Endocrine Therapy With Abemaciclib or Chemotherapy as Initial Metastatic Treatment in ER+/HER2- Breast Cancer
Clinical trial NCT04158362 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04158362
- Sponsor
- UNICANCER
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-11
- Primary completion
- 2025-04-30
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.